Abbasi, Siddique A.
Amgen (United States)
7 papers on CoChatORCID 0000-0002-9601-7565
Most cited papers
- Verified
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., et al. (2021) · New England Journal of Medicine
Heart Failure Treatment and ManagementCardiomyopathy and Myosin Studies
Cited by 656
- Verified
Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index
Shah, R. V., Murthy, V. L., Abbasi, S. A., Blankstein, R., Kwong, R. Y., Goldfine, A. B., Jerosch-Herold, M., Lima, J. A. C., Ding, J., & Allison, M. A. (2014) · JACC: Cardiovascular Imaging
Cardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 427
- Verified
Long-term evolocumab in patients with established atherosclerotic cardiovascular disease
O’Donoghue, M. L., Giugliano, R. P., Wiviott, S. D., Atar, D., Keech, A., Kuder, J. F., Im, K., Murphy, S. A., Flores-Arredondo, J. H., López, J. A. G., et al. (2022) · Circulation
Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases
Cited by 410
- Verified
Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation
Neilan, T. G., Farhad, H., Dodson, J. A., Shah, R. V., Abbasi, S. A., Bakker, J. P., Michaud, G. F., van der Geest, R., Blankstein, R., Steigner, M., et al. (2013) · Journal of the American Heart Association
Atrial Fibrillation Management and OutcomesObstructive Sleep Apnea Research
Cited by 158
- Verified · note
Association of Fitness in Young Adulthood With Survival and Cardiovascular Risk: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Shah, R. V., Murthy, V. L., Colangelo, L. A., Reis, J., Venkatesh, B. A., Sharma, R., Abbasi, S. A., Goff, D. C., Carr, J. J., Rana, J. S., et al. (2016) · JAMA Internal Medicine
Cardiovascular and exercise physiologyPhysical Activity and Health
Cited by 158
- Verified
Once-monthly maridebart cafraglutide for the treatment of obesity—a phase 2 trial
Jastreboff, A. M., Ryan, D. H., Bays, H. E., Ebeling, P. R., Mackowski, M. G., Philipose, N., Ross, L., Liu, Y., Burns, C. E., Abbasi, S. A., et al. (2025) · New England Journal of Medicine
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 110
- Verified
Impaired Fasting Glucose and Body Mass Index as Determinants of Mortality in ALLHAT: Is the Obesity Paradox Real?
Shah, R. V., Abbasi, S. A., Yamal, J., Davis, B. R., Barzilay, J., Einhorn, P. T., Goldfine, A., & the ALLHAT Collaborative Research Group (2014) · The Journal of Clinical Hypertension
Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free